�����Ƶ

John A. Griswold, MD, FACS

John A. Griswold, MD, FACS  Born and raised in Casper Wyoming, John Griswold obtained a Bachelor of Science from the University of Notre Dame then attended Creighton University for medical school, graduating in 1981. He subsequently completed a five-year general surgery residency at Texas Tech University Health Sciences Center.  Upon completion, he went to the University of Washington for a fellowship in burn research and burn clinical care.

At the University of Washington, his burn research was done in the Trauma Inflammation in the lab of Dr. Ron Meyer.  Dr. Griswold developed a working murine model of ARDS and acute lung injury and studied neutrophil dysfunction, which led to defining the microbiology behind the cause of ARDS.

After completing the burn fellowship, he joined the faculty at the University of Mississippi, Department of Surgery in the Division of Burns, Trauma and Critical Care. At the University of Mississippi, he set-up a busy basic science lab continuing to investigate pulmonary dysfunction and inflammation. He also began several clinical projects both investigator-initiated as well as industry sponsored. 

In 1992 Dr. Griswold was recruited back to Texas Tech University Health Sciences to begin the Level 1 Trauma Center and revamp the Burn Center. Both of these responsibilities demanded basic, clinical and translational research activities. In the area basic research Dr. Griswold began collaborating with Dr. Abdul Hamood in the Dept. of Microbiology, focusing on the pathophysiology of Pseudomonas in burn injury. Dr. Jane Colmer-Hamood later joined the two and the result has been 27-years of extremely successful collaboration, numerous grants, hundreds of peer-review publications including publications in JAMA and SCIENCE. This association also provided the foundation for training an extensive list of master students and PhD candidates. One of the highlights of this educational process was having the opportunity to work with Kendra Rumbaugh during her PhD, a collaboration that has been incredibly fruitful and fulfilling.

In June 1997 Dr. Griswold took over the reins of the Department of Surgery at Texas Tech University Health Sciences Center. “I inherited a department of 6 faculty, none who had any training or experience in research.  There were no active research projects other than those associated with the burn and trauma centers and most importantly there was no money to fund research. So I convinced two young, very bright nurses who worked in the SICU, Cathy Lovett and Stacey Pugh, to join me in developing a Division of Clinical Research in the Dept. of Surgery. We began the process with complex industry-sponsored clinical trials in the ICU that was a resounding success.  This led to Dr. Griswold being named Scientist of the Year in 2000, by the ARCS Foundation.  Over the next several years the clinical research grew in quantity, quality and financially. The clinical research division was then transitioned to the School of Medicine as the Division of Clinical Research. It eventually landed under the Office of President as the CRI, supporting research throughout the HSC.”

Dr. Griswold is honored to back working within the CRI.

Catherine (Cathy) Lovett, RN, MSN, CCRC, CCRP

Catherine (Cathy) Lovett, RN, MSN, CCRC, CCRP is the Managing Director of the Clinical Research Institute. This role in the CRI includes several diverse aspects of clinical research. She is responsible for the day-to-day operations of the department, developing and teaching educational programs, developing/negotiating budgets, as well as helping to develop the clinical research infrastructure for �����Ƶ and our affiliated hospital.

Cathy is a Registered Nurse; the majority of her experience is in the care of the critically ill adult patient. She received her Bachelor's of Science in Nursing in 1987 from West Texas State University and her Master's of Science in Nursing from Texas Tech University Health Sciences Center School of Nursing in 2008.

She is experienced in protocol design as well as conducting Phase 1 through Phase IV drug, device, industry and investigator initiated studies. Professional memberships include the International Association of Clinical Research Nurses, Association of Clinical Research Professionals, the Society of Clinical Research Associates, and the American Association of Critical Care nurses.